Abstract
Kaposi sarcoma is a vascular tumor of intermediate biological aggressiveness. It is also known as idiopathic multiple pigmented sarcoma of the skin, angiosarcoma multiplex, and granuloma multiplex hemorrhagicum.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Suggested Readings
Cesarman (2019) Kaposi sarcoma. Nat Rev Dis Primers 5(1):9
Dupin (2020) Update on oncogenesis and therapy for Kaposi sarcoma. Curr Opin Oncol 32(2):122–128
Etemad (2019) Kaposi sarcoma updates. Dermatol Clin 37(4):505–517
Fletcher (2020) WHO classification of tumours of soft tissue and bone (5th edition)
Galanina (2018) Successful treatment of HIV-associated Kaposi sarcoma with immune checkpoint blockade. Cancer Immunol Res 6(10):1129–1135
Krown (2020) Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial. Lancet 395(10231):1195–1207
Polizzotto (2016) Pomalidomide for symptomatic Kaposi’s sarcoma in people with and without HIV infection: a phase I/II study. J Clin Oncol 34(34):4125–4131
Rouhani (2008) Cutaneous soft tissue sarcoma incidence patterns in the U.S.: an analysis of 12,114 cases. Cancer 113(3):616–627
Schneider (2017) Diagnosis and treatment of Kaposi sarcoma. Am J Clin Dermatol 18(4):529–539
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Mocellin, S. (2021). Kaposi Sarcoma. In: Soft Tissue Tumors . Springer, Cham. https://doi.org/10.1007/978-3-030-58710-9_142
Download citation
DOI: https://doi.org/10.1007/978-3-030-58710-9_142
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-58709-3
Online ISBN: 978-3-030-58710-9
eBook Packages: MedicineMedicine (R0)